Skip to main content
Clinical Trials/IRCT20120516009772N2
IRCT20120516009772N2
Recruiting
Phase 3

The Efficacy and side effects of different doses of finastride/ dutastride accompanying with tamsulosin for Benign prostate hyperplasia in Iranian men

Shahid Beheshti University of Medical Sciences0 sites175 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
175
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • prostate size larger than 30 gram
  • moderate to sever symptom (ipss\>13\)
  • older than 55 years old
  • Qmax of 4–15 mL/s from a pre\-void bladder volume \=150 and \=550 mL (minimum voided volume 125 mL)
  • with \>6 months history of BPH\-LUTS

Exclusion Criteria

  • no surgical indication(bladder stone,uremia,urinary retention,gross hematuria,recurrent infection)
  • no previous prostate surgery
  • no urethral stricture
  • history of severe renal or hepatic insuf?ciency
  • History of bladder cancer or prostate cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials